sulpiride has been researched along with Chemical Dependence in 13 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patients aged 2 18 years who received an initial prescription for olanzapine, risperidone, quetiapine or amisulpride between April 1 and September 30, 2003; and had an ICD-10-coded diagnosis of schizophrenia were included." | 3.74 | Atypical antipsychotic therapy for treatment of schizophrenia in Hong Kong Chinese patients--a cost analysis. ( Hui, HY; Law, WL; You, JH; Young, WM, 2007) |
| "To measure behavioral and brain functional markers of drug-related attentional bias in stimulant-dependent individuals studied repeatedly after short-term dosing with dopamine D(2)/D(3) receptor antagonist and agonist challenges." | 1.36 | Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence. ( Abbott, S; Barnes, A; Bullmore, ET; Craig, KJ; Ersche, KD; Merlo-Pich, EV; Müller, U; Ooi, C; Robbins, TW; Sahakian, BJ; Shabbir, SS; Suckling, J, 2010) |
| "Pretreatment with diazepam (0." | 1.31 | Anxiogenic-like effects limit rewarding effects of cocaine in balb/cbyj mice. ( Cazala, P; David, V; Gold, LH; Koob, GF, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoenicka, J | 1 |
| Quiñones-Lombraña, A | 1 |
| España-Serrano, L | 1 |
| Alvira-Botero, X | 1 |
| Kremer, L | 1 |
| Pérez-González, R | 1 |
| Rodríguez-Jiménez, R | 1 |
| Jiménez-Arriero, MA | 1 |
| Ponce, G | 1 |
| Palomo, T | 1 |
| Ersche, KD | 1 |
| Bullmore, ET | 1 |
| Craig, KJ | 1 |
| Shabbir, SS | 1 |
| Abbott, S | 1 |
| Müller, U | 1 |
| Ooi, C | 1 |
| Suckling, J | 1 |
| Barnes, A | 1 |
| Sahakian, BJ | 1 |
| Merlo-Pich, EV | 1 |
| Robbins, TW | 1 |
| Law, WL | 1 |
| Hui, HY | 1 |
| Young, WM | 1 |
| You, JH | 1 |
| Rizzo, F | 1 |
| Cervo, L | 1 |
| Samanin, R | 1 |
| Spangler, R | 1 |
| Zhou, Y | 1 |
| Maggos, CE | 1 |
| Zlobin, A | 1 |
| Ho, A | 1 |
| Kreek, MJ | 1 |
| Thomas, MJ | 1 |
| Malenka, RC | 1 |
| Bonci, A | 1 |
| David, V | 1 |
| Gold, LH | 1 |
| Koob, GF | 1 |
| Cazala, P | 1 |
| Carrère, J | 1 |
| Roux, JM | 1 |
| De Maio, D | 1 |
| Caponeri, MA | 1 |
| Mellado, C | 1 |
| Scieghi, G | 1 |
| Cicchetti, V | 1 |
| Planche, S | 1 |
| Benazzi, F | 1 |
| Stein, L | 1 |
| Belluzzi, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Dopamine D2/3- and μ-opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity in Healthy Volunteers[NCT02557984] | 121 participants (Actual) | Interventional | 2014-02-28 | Completed | |||
| Allelic Linkage in Substance Abuse[NCT00247819] | 8,000 participants (Anticipated) | Observational | 1992-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for sulpiride and Chemical Dependence
| Article | Year |
|---|---|
[Studies on the use of sulpiride as an anticenestopathic agent. Findings in drug-dependent and hypochondriac patients].
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Evaluation; Humans; Hypochondriasis; Male; Substan | 1976 |
[Sulpiride and drug addiction].
Topics: Adolescent; Adult; Anxiety; Clinical Trials as Topic; Delusions; Female; Hallucinations; Humans; Lys | 1975 |
11 other studies available for sulpiride and Chemical Dependence
| Article | Year |
|---|---|
The ANKK1 gene associated with addictions is expressed in astroglial cells and upregulated by apomorphine.
Topics: Animals; Apomorphine; Astrocytes; Cells, Cultured; Central Nervous System; Dopamine Agonists; Embryo | 2010 |
Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence.
Topics: Adult; Amisulpride; Amphetamine-Related Disorders; Attention; Benzothiazoles; Bias; Cerebellar Corte | 2010 |
Atypical antipsychotic therapy for treatment of schizophrenia in Hong Kong Chinese patients--a cost analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; China; Cost of Illness; Cost-Benefit Anal | 2007 |
[The need for psychopharmacologic therapy of drug addicts with acute hepatitis].
Topics: Acute Disease; Diazepam; Drug Therapy, Combination; Hepatitis; Heroin Dependence; Humans; Methadone; | 1984 |
Effects of dopaminergic and glutamatergic receptor antagonists on the establishment and expression of conditioned locomotion to cocaine in rats.
Topics: Analysis of Variance; Animals; Benzazepines; Cocaine; Conditioning, Psychological; Dizocilpine Malea | 1996 |
Dopamine antagonist and "binge' cocaine effects on rat opioid and dopamine transporter mRNAs.
Topics: Analysis of Variance; Animals; Benzazepines; Brain; Carrier Proteins; Cocaine; DNA Primers; Dopamine | 1996 |
Modulation of long-term depression by dopamine in the mesolimbic system.
Topics: Animals; Benzazepines; Conditioning, Psychological; Dopamine; Dopamine Agonists; Dopamine Antagonist | 2000 |
Anxiogenic-like effects limit rewarding effects of cocaine in balb/cbyj mice.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Brain; Caudate Nucleus; Cocaine; Conditioning, Operant; Diaze | 2001 |
[Sulpiride in the withdrawal of non-ethylic drug addiction].
Topics: Anti-Anxiety Agents; Antiparkinson Agents; Female; Humans; Hypnotics and Sedatives; Male; Meperidine | 1976 |
Lorazepam, amitriptyline, and sulpiride: withdrawal effects.
Topics: Amitriptyline; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Lo | 1991 |
Second messengers, natural rewards, and drugs of abuse.
Topics: Benzazepines; Brain; Cyclic AMP; Diglycerides; Dopamine; Glycerides; Hippocampus; Humans; Inositol 1 | 1986 |